This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Related articles in Am J Pathol Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fan, X. Articles by Eberhart, C. G. Search for Related Content PubMed PubMed Citation Articles by Fan, X. Articles by Eberhart, C. G.

(American Journal of Pathology. 2003;162:1763-1769.)
© 2003 American Society for Investigative Pathology

Short Communication

hTERT Gene Amplification and Increased mRNA Expression in Central Nervous System Embryonal Tumors

Xing Fan^*, Yunyue Wang^*, John Kratz^*, Dan J. Brat, Yves Robitaille, Albert Moghrabi, Elizabeth J. Perlman, Chi V. Dang^*, Peter C. Burger^* and Charles G. Eberhart^*

From The Johns Hopkins University School of Medicine,^* Baltimore, Maryland; L’hôpital Ste-Justine, Montreal, Canada; Emory University Medical Center, Atlanta, Georgia; and the Children’s Memorial Hospital, Chicago, Illinois

High-level gains at 5p15, a chromosomal region including the human telomerase catalytic protein subunit (hTERT) gene, have been documented in several medulloblastomas. We therefore analyzed hTERT gene dosage in a group of medulloblastomas and other embryonal brain tumors using differential PCR. Amplification of the hTERT locus was detected in 15 of 36 (42%) tumors examined. To correlate gene amplification with message level, we used real-time quantitative PCR to measure hTERT mRNA in 50 embryonal brain tumors. hTERT mRNA was detected in all but one of these cases, and mRNA level correlated significantly with gene dosage (r = 0.82). Log-rank analysis of survival data revealed a trend toward poor clinical outcomes in patients with medulloblastomas containing high hTERT mRNA levels, but clinical follow-up was relatively short and the association was not statistically significant (P = 0.078). Comparative genomic hybridization was used to further analyze the tumor with the greatest hTERT gene dosage and mRNA level, a recurrent medulloepithelioma. hTERT was amplified in the recurrent tumor but not in the primary lesion, suggesting this locus can be involved in tumor progression. Our data indicate that hTERT gene amplification is relatively common in embryonal brain tumors, and that increased expression of hTERT mRNA may be associated with biologically aggressive tumor behavior.

Related articles in Am J Pathol:

This Month in AJP

Am J Pathol 2003 162: 1745-1746. [Full Text]  

This article has been cited by other articles:

				M. Provencal, D. Labbe, R. Veitch, D. Boivin, G.-E. Rivard, H. Sartelet, Y. Robitaille, D. Gingras, and R. Beliveau c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration Carcinogenesis, July 1, 2009; 30(7): 1089 - 1096. [Abstract] [Full Text] [PDF]

				Y. Cao, L. I. Huschtscha, A. S. Nouwens, H. A. Pickett, A. A. Neumann, A. C-M. Chang, C. D. Toouli, T. M. Bryan, and R. R. Reddel Amplification of Telomerase Reverse Transcriptase Gene in Human Mammary Epithelial Cells with Limiting Telomerase RNA Expression Levels Cancer Res., May 1, 2008; 68(9): 3115 - 3123. [Abstract] [Full Text] [PDF]

				J. M. de Bont, R. J. Packer, E. M. Michiels, M. L. d. Boer, and R. Pieters Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective Neuro-oncol, January 1, 2008; 10(6): 1040 - 1060. [Abstract] [Full Text] [PDF]

				T. Li, H. Wen, C. Brayton, P. Das, L. A. Smithson, A. Fauq, X. Fan, B. J. Crain, D. L. Price, T. E. Golde, et al. Epidermal Growth Factor Receptor and Notch Pathways Participate in the Tumor Suppressor Function of {gamma}-Secretase J. Biol. Chem., November 2, 2007; 282(44): 32264 - 32273. [Abstract] [Full Text] [PDF]

				D. Stearns, A. Chaudhry, T. W. Abel, P. C. Burger, C. V. Dang, and C. G. Eberhart c-Myc Overexpression Causes Anaplasia in Medulloblastoma Cancer Res., January 15, 2006; 66(2): 673 - 681. [Abstract] [Full Text] [PDF]

				F. Mendrzyk, B. Radlwimmer, S. Joos, F. Kokocinski, A. Benner, D. E. Stange, K. Neben, H. Fiegler, N. P. Carter, G. Reifenberger, et al. Genomic and Protein Expression Profiling Identifies CDK6 As Novel Independent Prognostic Marker in Medulloblastoma J. Clin. Oncol., December 1, 2005; 23(34): 8853 - 8862. [Abstract] [Full Text] [PDF]

				Y. Li, B. Lal, S. Kwon, X. Fan, U. Saldanha, T. E. Reznik, E. B. Kuchner, C. Eberhart, J. Laterra, and R. Abounader The Scatter Factor/Hepatocyte Growth Factor: c-Met Pathway in Human Embryonal Central Nervous System Tumor Malignancy Cancer Res., October 15, 2005; 65(20): 9355 - 9362. [Abstract] [Full Text] [PDF]

				E. Pan, M. Pellarin, E. Holmes, I. Smirnov, A. Misra, C. G. Eberhart, P. C. Burger, J. A. Biegel, and B. G. Feuerstein Isochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma Patients Clin. Cancer Res., July 1, 2005; 11(13): 4733 - 4740. [Abstract] [Full Text] [PDF]

				D. Williamson, Y.-J. Lu, T. Gordon, R. Sciot, A. Kelsey, C. Fisher, C. Poremba, J. Anderson, K. Pritchard-Jones, and J. Shipley Relationship Between MYCN Copy Number and Expression in Rhabdomyosarcomas and Correlation With Adverse Prognosis in the Alveolar Subtype J. Clin. Oncol., February 1, 2005; 23(4): 880 - 888. [Abstract] [Full Text] [PDF]

				X. Fan, I. Mikolaenko, I. Elhassan, X. Ni, Y. Wang, D. Ball, D. J. Brat, A. Perry, and C. G. Eberhart Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth Cancer Res., November 1, 2004; 64(21): 7787 - 7793. [Abstract] [Full Text] [PDF]